Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study of CAR-T Therapy in Older Patients
A clinical trial update describing a CAR-T therapy study enrolling older adults with B-cell lymphomas and multiple myeloma, currently recrui…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) [Phase 1]
Phase 1 study evaluating NT-I7 (recombinant human interleukin-7) in relapsed/refractory multiple myeloma patients who previously received BC…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy [Phase 3]
This is a Phase 3 clinical trial update evaluating lenalidomide plus subcutaneous daratumumab versus lenalidomide plus dexamethasone in frai…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma [Phase 1]
A Phase 1 clinical trial is evaluating mezigdomide (CC-92480) in relapsed multiple myeloma patients who have previously received idecabtagen…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years [Phase 3]
This Phase 3 trial compares conventional-dose lenalidomide, bortezomib, and dexamethasone (RVD) against high-dose therapy with autologous st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating PD-1 blockade in conjunction with dendritic cell/myeloma vaccine…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Maintenance Therapy Using Lenalidomide in Myeloma [Phase 3]
Phase 3 clinical trial evaluating maintenance therapy with lenalidomide in multiple myeloma has completed.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma [Phase 3]
A Phase 3 study evaluating Gammagard Liquid (intravenous immunoglobulin 10%) to prevent infections in adults with multiple myeloma is curren…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1) [Phase 1, Phase 2]
Clinical trial DURGA-1 evaluating AZD0120 in relapsed/refractory multiple myeloma is in Phase 1/Phase 2 and currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia [Phase 2]
Phase 2 clinical trial evaluating IL-15-Armored CAR-T therapy in relapsed or refractory multiple myeloma and plasma cell leukemia; currently…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating genetically engineered MUC1-activated T-cells for treating recurrent or refractory multiple myeloma, spons…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
A clinical trial update on Daratumumab-Pomalidomide-Dexamethasone (Dara-PD) for patients with first-relapse multiple myeloma; the study is c…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Clinical update on a Phase 1/Phase 2 study of mRNA-2808 in participants with relapsed or refractory multiple myeloma; the trial is currently…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial sponsored by Hoffmann-La Roche to evaluate multiple treatments for adults with multiple myeloma; the stu…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
Clinical trial update for Eque-cel in relapsed/refractory multiple myeloma; the study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients [NA]
A University of Chicago-sponsored study is evaluating measurable residual disease in multiple myeloma patients, with the trial currently act…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) [Phase 3]
Open-label Phase 3 trial comparing Iberdomide with Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: ATRA and Carfilzomib in Plasma Cell Myeloma Patients [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the combination of all-trans retinoic acid (ATRA) and carfilzomib in patie…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial [Phase 3]
A Phase 3 study named EQUATE is testing a combination therapy for adults with newly diagnosed multiple myeloma, and the trial is currently r…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients [Phase 3]
This entry describes a Phase 3 trial comparing elranatamab plus lenalidomide consolidation and/or elranatamab maintenance versus standard of…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant [Phase 2]
Phase 2 trial investigating whether Ide-cel (idecabtagene vicleucel) can be manufactured from patients with multiple myeloma who have previo…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer [Phase 2]
TAPUR is a Phase 2 study testing FDA-approved cancer drugs that target specific tumor gene abnormalities in patients with advanced cancers; …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) [Phase 1]
A Phase 1 study evaluating ISB 2001 in relapsed/refractory multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma [Phase 1]
A Phase 1 clinical trial evaluating BCMA-directed CAR-T cell therapy in adults with multiple myeloma was terminated.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Survivors Uniting for Remote Guided Exercise [NA]
Clinical trial update from Colorado State University about a remote guided exercise program for cancer survivors; the study is currently rec…